Insider Buying Activity Highlights Key Holdings in AGF U.S. Market Neutral Anti-Beta Fund
A significant 54.0% of the weighted holdings in the AGF U.S. Market Neutral Anti-Beta Fund (BTAL) have recorded insider buying in the past six months, reflecting potential investor confidence.
DENTSPLY SIRONA Inc (Symbol: XRAY), constituting 32.37% of the fund, has seen two directors and officers purchase shares within the last six months, based on recent Form 4 data. The ETF holds $1,336,893 worth of XRAY, ranking it as the #68 largest position. Below is a summary of the recent insider buying for XRAY:
XRAY — last trade: $19.16 — Recent Insider Buys:
| Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|
| 08/08/2024 | Gregory T. Lucier | Director | 8,212 | $24.35 | $199,983 |
| 11/12/2024 | Simon D. Campion | President, CEO & Member of BOD | 11,306 | $17.72 | $200,341 |
| 11/18/2024 | Gregory T. Lucier | Director | 6,000 | $18.35 | $110,129 |
AGCO Corp. (Symbol: AGCO) is the #147 largest holding in the AGF U.S. Market Neutral Anti-Beta Fund (BTAL), with two directors and officers recently filing to indicate share purchases. The ETF has invested $1,260,962 in AGCO, making up about 30.53% of its total assets as of the latest report. Below is the recent insider buying activity at AGCO:
AGCO — last trade: $93.63 — Recent Insider Buys:
| Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|
| 08/07/2024 | Michael C. Arnold | Director | 1,800 | $87.69 | $157,842 |
| 08/08/2024 | Bob De Lange | Director | 1,415 | $88.28 | $124,916 |
| 08/05/2024 | Bob De Lange | Director | 1,420 | $87.91 | $124,832 |
| 11/14/2024 | Bob De Lange | Director | 2,740 | $91.80 | $251,532 |
10 ETFs With Stocks That Insiders Are Buying »
Also see:
• CNC Options Chain
• REXR Stock Predictions
• KMI Next Dividend Date
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
